ECL
54
-5
CA
42
12
BA
45
-2
CTAS
39
-3
AMGN
31
-3
DAL
65
-3
CMI
69
-2
CAH
61
-5
EQIX
65
-2
ED
43
-2
EQT
50
-3
AMP
61
-3
AMG
75
-4
DD
34
-4
BAX
38
-3
CFG
87
-2
ACN
47
-7
AON
63
-2
ADP
51
-4
CB
62
-5
ECL
54
-5
CA
42
12
BA
45
-2
CTAS
39
-3
AMGN
31
-3
DAL
65
-3
CMI
69
-2
CAH
61
-5
EQIX
65
-2
ED
43
-2
EQT
50
-3
AMP
61
-3
AMG
75
-4
DD
34
-4
BAX
38
-3
CFG
87
-2
ACN
47
-7
AON
63
-2
ADP
51
-4
CB
62
-5
Financhill
Back

Milestone Pharmaceuticals, Inc. Vs. Rapt Therapeutics, Inc. Industry Stock Comparison

Sell
43

MIST
Milestone Pharmaceuticals, Inc.

Last Price:
$2.02
Seasonality Move:
-24.48%
Sell
38

RAPT
Rapt Therapeutics, Inc.

Last Price:
$33.91
Seasonality Move:
-28.15%
Sell
43
Milestone Pharmaceuticals, Inc. (MIST) is a Sell

Is Milestone Pharmaceuticals, Inc. a Buy, Sell or Hold?

  • The current Milestone Pharmaceuticals, Inc. [MIST] share price is $2.02. The Score for MIST is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
  • MIST is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
38
Rapt Therapeutics, Inc. (RAPT) is a Sell

Is Rapt Therapeutics, Inc. a Buy, Sell or Hold?

  • The current Rapt Therapeutics, Inc. [RAPT] share price is $33.87. The Score for RAPT is 38, which is 24% below its historic median score of 50, and infers higher risk than normal.
  • RAPT is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

MIST Stock Price Chart

What is Milestone Pharmaceuticals, Inc.'s stock price today?

  • The Milestone Pharmaceuticals, Inc. share price today is $2.02
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and MIST is experiencing slight buying pressure.

RAPT Stock Price Chart

What is Rapt Therapeutics, Inc.'s stock price today?

  • The Rapt Therapeutics, Inc. share price today is $33.87
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RAPT is experiencing slight buying pressure.

MIST Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.08 Sell
Relative Strength Index (14 RSI): 41.14 Sell
Chaikin Money Flow: 902933 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (2.08 - 2.68) Sell
Bollinger Bands (100): (1.73 - 2.33) Sell

RAPT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 9.53 Buy
Relative Strength Index (14 RSI): 51.15 Buy
Chaikin Money Flow: 79100 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (32.58 - 35.84) Sell
Bollinger Bands (100): (16.83 - 33.91) Buy

MIST Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 2.04 Sell
20-day SMA: 2.32 Sell
50-day SMA: 2.18 Sell
200-day SMA: 1.76 Buy
8-day EMA: 2.07 Sell
20-day EMA: 2.19 Sell
50-day EMA: 2.05 Sell
200-day EMA: 1.03 Buy

RAPT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 35 Sell
20-day SMA: 34.72 Sell
50-day SMA: 31.71 Buy
200-day SMA: 17.02 Buy
8-day EMA: 31.84 Buy
20-day EMA: 21.97 Buy
50-day EMA: 11.45 Buy
200-day EMA: 3.3 Buy

Milestone Pharmaceuticals, Inc. Earnings Growth & MIST Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.07 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.12 per share, and a decrease next year of $0.31 per share.

Rapt Therapeutics, Inc. Earnings Growth & RAPT Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.09 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.65 per share, and a decrease next year of $1.22 per share.

Milestone Pharmaceuticals, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Rapt Therapeutics, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):